ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

April 23, 1982

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

Funding Opportunities: RFA: Cancer Research Network Across Health Care Systems

September 12, 1997

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002

NCI CTEP-Approved Trials For the Month of May

May 30, 2014

NCI Provides $40 Million To Four Centers For Cancer Communications Research.

June 27, 2003